Public Health Agency of Sweden, Nobels väg 18, 17182 Solna, Stockholm, Sweden.
Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Alfred Nobels allé 10, 141 52 Huddinge, Stockholm, Sweden.
Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2347-2354. doi: 10.1007/s10096-018-3382-8. Epub 2018 Oct 18.
We investigated the faecal carriage prevalence of extended-spectrum β-lactamase production in Escherichia coli (EP-EC) and/or Klebsiella pneumoniae (EP-KP) and risk factors associated with carriage among adult study subjects in Finland, Germany, Latvia, Poland, Russia and Sweden (partner countries). The aim was to get indicative data on the prevalence of ESBL-carriage in specific populations in the region. Faecal samples were collected from four study populations and screened on ChromID-ESBL and ChromID-OXA-48 plates. Positive isolates were further characterised phenotypically. Our results show a large variation in carrier prevalence ranging from 1.6% in Latvia to 23.2% in Russia for EP-EC. For the other partner countries, the prevalence of EP-EC were in increasing numbers, 2.3% for Germany, 4.7% for Finland, 6.6% for Sweden, 8.0% for Poland and 8.1% for all partner countries in total. Carriers of EP-KP were identified only in Finland, Russia and Sweden, and the prevalence was < 2% in each of these countries. No carriers of carbapenemase-producing isolates were identified. This is the first study reporting prevalence of carriers (excluding traveller studies) for Finland, Latvia, Poland and Russia. It contributes with important information regarding the prevalence of EP-EC and EP-KP carriage in regions where studies on carriers are limited.
我们研究了芬兰、德国、拉脱维亚、波兰、俄罗斯和瑞典(合作伙伴国家)成年研究对象中携带产extended-spectrum β-lactamase(ESBL)的大肠埃希菌(EP-EC)和/或肺炎克雷伯菌(EP-KP)的粪便携带率及相关危险因素。目的是获得该地区特定人群中 ESBL 携带率的指示性数据。从四个研究人群中采集粪便样本,并在 ChromID-ESBL 和 ChromID-OXA-48 平板上进行筛选。阳性分离株进一步进行表型特征分析。结果显示,携带率存在很大差异,从拉脱维亚的 1.6%到俄罗斯的 23.2%不等。对于其他合作伙伴国家,EP-EC 的携带率呈递增趋势,德国为 2.3%,芬兰为 4.7%,瑞典为 6.6%,波兰为 8.0%,所有合作伙伴国家总计为 8.1%。仅在芬兰、俄罗斯和瑞典发现了 EP-KP 的携带者,且每个国家的携带率均<2%。未发现产碳青霉烯酶分离株的携带者。这是首次报道芬兰、拉脱维亚、波兰和俄罗斯(不包括旅行者研究)携带者的流行率的研究。它为在携带者研究有限的地区提供了有关 EP-EC 和 EP-KP 携带率的重要信息。